![Stephen Tulipano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Tulipano
Företagsledare/Principal på
The American Institute of Certified Public Accountants
Profil
Stephen J.
Tulipano is currently a Member at The American Institute of Certified Public Accountants and a Member at the Massachusetts Society of Certified Public Accountants, Inc. Previously, he worked as the Director-Corporate Accounting at Biogen, Inc. from 1998 to 2006.
He also served as the Manager-External Reporting at Digital Equipment Corp.
Additionally, he held the position of Chief Financial Officer & Treasurer at Aldeyra Therapeutics, Inc. from 2014 to 2018 and Chief Financial Officer & Secretary at Javelin Pharmaceuticals, Inc. from 2009 to 2010.
Currently, he is the Chief Financial Officer at Stoke Therapeutics, Inc. from 2019 to 2024.
Mr. Tulipano obtained his undergraduate degree from Salem State University and his MBA from Sawyer Business School.
Aktiva positioner av Stephen Tulipano
| Företag | Position | Start |
|---|---|---|
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Företagsledare/Principal | - |
Massachusetts Society of Certified Public Accountants, Inc.
 Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization for CPAs | Företagsledare/Principal | - |
Tidigare kända positioner av Stephen Tulipano
| Företag | Position | Slut |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Finansdirektör/CFO | 2024-05-07 |
| ALDEYRA THERAPEUTICS, INC. | Finansdirektör/CFO | 2018-07-31 |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Finansdirektör/CFO | 2010-07-01 |
| BIOGEN INC. | Comptroller/Controller/Revisor | 2006-04-01 |
Digital Equipment Corp.
 Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Företagsledare/Principal | - |
Stephen Tulipanos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
82
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Digital Equipment Corp.
Digital Equipment Corp. Computer Processing HardwareElectronic Technology Makes personal computers and servers | Electronic Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
Salem State University
 Salem State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Javelin Pharmaceuticals, Inc.
Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Massachusetts Society of Certified Public Accountants, Inc.
Massachusetts Society of Certified Public Accountants, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization for CPAs | Commercial Services |
Sawyer Business School
 Sawyer Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
